South East Asia Defibrillators Market To Reach $371.88 Million By 2030

South East Asia Defibrillators Market Growth & Trends

The South East Asia defibrillators market size is anticipated to reach USD 371.88 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.83% from 2024 to 2030. The SEA defibrillator market’s growth is propelled by several critical factors, including technological advancements, rising cases of cardiac arrests, favorable government initiatives and healthcare policies.

Physical inactivity is a major public health concern as it has led to the second-highest number of deaths after the consumption of tobacco globally. A sedentary lifestyle leads to morbidity and the development of chronic conditions, such as diabetes and cardiac disorders. Physical inactivity is often associated with aggravation of symptoms of chronic conditions, including atherosclerotic and diabetic patients. Major consequences of this lifestyle are cardiac disorders, such as myocardial infarction, stroke, and angina. Most of the population suffering from cardiac disorder symptoms are thus advised at least 150 minutes of physical activity daily with a minimum of 75 minutes, especially in men. According to WHO, around 2 million people die annually due to physical inactivity, and around 60.0% to 85.0% of individuals globally follow sedentary lifestyles, making it a major public health concern.

Defibrillators such as implantable cardioverter defibrillators (ICDs), automated external defibrillators (AEDs), and wearable cardioverter defibrillators, cater to a diverse range of patients from adults to pediatrics. The demand for defibrillators in SEA is on the rise due to increasing awareness of cardiovascular diseases and sudden cardiac arrest incidents. This growing demand drives imports as local manufacturing may not meet the required supply levels. According to Volza Philippines Import data, 982 defibrillator shipments were imported by 155 Philippine Importers from 235 Suppliers, primarily from China, Hong Kong, and the United States. The top importers were India, Vietnam, and Brazil.

 Request a free sample copy or view report summary: South East Asia Defibrillators Market Report

South East Asia Defibrillators Market Report Highlights

• Based on product, the external defibrillator segment commanded the most significant revenue share, accounting for 53.61%, in 2023

• The growing elderly population, the incorporation of advanced technology, increased investments from both government and private manufacturers, and heightened awareness campaigns about cardiovascular disorders all contribute to the increased utilization of external defibrillators, propelling the growth of the external defibrillator segment

• Based on end use, the hospital segment is dominant due to its investment in advanced technology to enhance emergency response capabilities and maintain compliance with global healthcare standards

South East Asia Defibrillators Market Segmentation

Grand View Research has segmented the South East Asia defibrillators market based on product, end use, and region:

SEA Defibrillator Product Outlook (Revenue, USD Million, 2018 - 2030)

• Implantable Cardioverter Defibrillator (ICD)

  • S-ICD

  • T-ICD

    • Single Chamber

    • Dual Chamber

    • CRT-D

• External Defibrillator

  • Manual ED

  • Automated ED

  • Wearable cardioverter defibrillators

SEA Defibrillator End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Pre hospital

• Public Access market

• Alternate care market

• Home healthcare

SEA Defibrillator Regional Outlook (Revenue, USD Million, 2018 - 2030)

• South East Asia

  • Singapore

  • Philippines

  • Thailand

  • Malaysia

  • Indonesia

  • Rest of South East Asia

List of Key Players in the South East Asia Defibrillators Market

• Medtronic

• St. Jude Medical, LLC

• Boston Scientific Corporation

• Philips

• Zoll Medical Corporation

• Cardiac Science

• Physio-Control Inc.

• Nihon Kohden Corporation

• Progetti Srl

• FUKUDA DENSHI

• Schiller AG